CVS/pharmacy expands role of two field executives
Woonsocket, R.I. — CVS/pharmacy on Thursday expanded the role of two retail field executives as senior VP operations Dennis Palmer, a 37-year retail veteran, announced his retirement.
Effective Nov. 5, Hanley Wheeler, SVP operations has assumed responsibility of CVS/pharmacy’s Western and Southwestern markets while continuing to have responsibility for the company’s retail operations in its Midwest and Southeast markets.
Assuming responsibility for CVS/pharmacy’s retail operations in the Northeast and Mid-Atlantic is Kevin Hourican, SVP operations, who joined the CVS/pharmacy in June 2012 from Macy’s.
A pharmacist by training, Wheeler began his career at CVS/pharmacy in 1994 as an area VP. During his tenure at CVS and among his many accomplishments, Wheeler played a key role in the successful conversion of the acquired Osco and Sav-on stores, and led CVS/pharmacy’s organic growth into Chicago, Southern California, Las Vegas and Phoenix, as well as its entry into Puerto Rico, the company’s first market outside of the 50 U.S. states.
Prior to joining CVS/pharmacy, Hourican served as Macy’s SVP and Mid-Atlantic regional director of stores. He also served as Macy’s SVP direct-to-consumer logistics and worked for Sears from 1999 through 2006 in a series of increasingly responsible operational roles.
Stuart Weitzman grows executive team to support growth
New York — Stuart Weitzman said Thursday that it has promoted Susan Duffy from senior VP global marketing to the position of chief marketing officer, as part of the luxury retailer’s plan for new market expansion.
As CMO, Duffy is charged with leading marketing, advertising, public relations and social media to ensure the branding message is consistent across all worldwide communications platforms.
Sally Ross has joined the company in the newly created role of chief merchandising officer of retail, focusing on defining and executing merchandising and visual strategies. Most recently, Ross was executive VP of merchandising for footwear at The Jones Group.
Effective Nov. 12, Jonathan Lelonek will join Stuart Weitzman as executive VP US wholesale, and Samara Hodgson joined the team as VP social and digital innovation.
Stuart Weitzman is a division of The Jones Group.
Walmart to sell hypertension drugs for 1 cent
BENTONVILLE, Ark. — Members of a prescription drug program offered by Humana to Medicare beneficiaries will soon be able to obtain hypertension drugs from Walmart for a penny.
That’s right: $0.01.
Walmart and Humana said that starting in 2013, members of the Humana-Walmart-Preferred Rx Plan would have access to 10 drugs for high blood pressure for 1 cent each when filled at a Walmart or Sam’s Club store. The companies said the price meant members would pay that much for them through all phases of their benefit, regardless of whether they have met their deductibles or are in the coverage gap.
"We are committed to making pharmaceuticals more affordable so our customers can ultimately live healthier lives," Walmart health and wellness division president John Agwunobi said. "The Humana-Walmart-Preferred Rx Plan will help eliminate out-of-pocket costs for high blood pressure treatments so more patients can follow the regimen prescribed by their physicians."
The drugs offered under the program are lisinopril, hydrochlorothiazide, metoprolol tartrate, atenolol, lisinopril-hydrochlorothiazide, triamterene-hydrochlorothiazide, enalapril maleate, benazepril, nadolol and captopril.
"A recent study from the Centers for Disease Control and Prevention found that close to 70% of Medicare beneficiaries aged 65 and older have hypertension," Humana Pharmacy Solutions president William Fleming said, citing a CDC National Center for Health Statistics study released in May. "This statistic underscores the importance of offering affordable, high-quality prescription drugs to baby boomers and other beneficiaries as part of the Humana-Walmart Preferred Rx Plan."